The drug, Aimovig, made by Amgen and Novartis, is a monthly injection with a device similar to an insulin pen. Aimovig blocks a protein fragment, CGRP, that instigates and perpetuates migraines
from Health https://ift.tt/2KQP9Eq
Thursday, May 24, 2018
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment